Pharmaceutical

September 2018

David Pyott: The Battle for Allergan (A)

By Lisa Duke, Randall Peterson

This case series charts the evolution of the hostile battle for Allergan and its ultimate sale to a white knight, Actavis. David Pyott had been the CEO of Allergan since January 1998; only the third…